<DOC>
	<DOCNO>NCT03006965</DOCNO>
	<brief_summary>The purpose study describe pharmacokinetic profile patient hemophilia A prophylaxis Spain use myPKFit®</brief_summary>
	<brief_title>Pharmacokinetic Characterization Hemophilia A Population Spain Using myPKFiT®</brief_title>
	<detailed_description>This pharmacokinetic profile obtain patient use Advate® ( human Factor VIII ) myPKFiT® . This patient follow period 12 month , pharmacokinetic measure collect 2 blood sample , presence Factor VIII determine usual clinical method : chromogenic method coagulative method .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Male patient . Age 1 65 year old . Patients diagnose Hemophilia A prophylactic treatment Advate® Patients old 18 sign inform consent form . In case mature minor , addition consent sign legal guardian , assent minor must obtain . In case patient legally incapable give consent , primary caregiver consent patient 's legal guardian . Withdrawal inform consent . Patients medical psychological condition accord researcher 's . criterion prevents follow usual clinical practice procedure . Patients concomitant diagnosis haemostasis disorder . Patients treated induction immunologic tolerance time inclusion .</criteria>
	<gender>Male</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>hemophilia</keyword>
	<keyword>Hemophilia A</keyword>
	<keyword>Factor VIII</keyword>
	<keyword>Advate</keyword>
	<keyword>Antithrombotic factor</keyword>
	<keyword>Pharmacokinetic dosing</keyword>
	<keyword>hemarthrosis</keyword>
	<keyword>myPKFiT</keyword>
</DOC>